Two Sigma Advisers LP Takes $473,000 Position in Schrödinger, Inc. (NASDAQ:SDGR)

Two Sigma Advisers LP bought a new stake in shares of Schrödinger, Inc. (NASDAQ:SDGR - Free Report) during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The firm bought 24,500 shares of the company's stock, valued at approximately $473,000.

Other institutional investors have also added to or reduced their stakes in the company. Point72 Hong Kong Ltd bought a new stake in shares of Schrödinger in the 4th quarter valued at about $27,000. Paradigm Asset Management Co. LLC acquired a new stake in Schrödinger in the 4th quarter worth approximately $50,000. KBC Group NV boosted its stake in Schrödinger by 73.9% in the 4th quarter. KBC Group NV now owns 4,361 shares of the company's stock worth $84,000 after purchasing an additional 1,853 shares in the last quarter. XTX Topco Ltd acquired a new stake in Schrödinger in the 4th quarter worth approximately $199,000. Finally, Bayesian Capital Management LP acquired a new stake in Schrödinger in the 4th quarter worth approximately $199,000. Hedge funds and other institutional investors own 79.05% of the company's stock.

Schrödinger Stock Performance

NASDAQ SDGR traded up $0.78 during mid-day trading on Friday, reaching $24.62. 1,167,173 shares of the stock were exchanged, compared to its average volume of 876,240. The business's 50 day moving average is $23.05 and its 200-day moving average is $22.32. The company has a market capitalization of $1.81 billion, a P/E ratio of -10.52 and a beta of 1.63. Schrödinger, Inc. has a 1 year low of $16.60 and a 1 year high of $28.47.

Schrödinger (NASDAQ:SDGR - Get Free Report) last posted its quarterly earnings data on Wednesday, May 7th. The company reported ($0.82) earnings per share for the quarter, missing analysts' consensus estimates of ($0.81) by ($0.01). The company had revenue of $59.55 million for the quarter, compared to analyst estimates of $54.60 million. Schrödinger had a negative return on equity of 35.77% and a negative net margin of 91.84%. The business's revenue was up 62.7% on a year-over-year basis. During the same quarter in the prior year, the company posted ($0.86) earnings per share. Equities analysts predict that Schrödinger, Inc. will post -2.37 earnings per share for the current fiscal year.

Analyst Upgrades and Downgrades

A number of research firms recently commented on SDGR. KeyCorp lifted their target price on shares of Schrödinger from $30.00 to $32.00 and gave the stock an "overweight" rating in a research note on Wednesday, April 16th. Piper Sandler dropped their price objective on shares of Schrödinger from $50.00 to $45.00 and set an "overweight" rating on the stock in a report on Thursday, February 27th. One analyst has rated the stock with a hold rating, four have given a buy rating and one has issued a strong buy rating to the company's stock. Based on data from MarketBeat, Schrödinger currently has a consensus rating of "Buy" and a consensus target price of $32.80.

Insider Activity

In other news, insider Karen Akinsanya sold 16,723 shares of the stock in a transaction dated Monday, April 14th. The shares were sold at an average price of $25.09, for a total value of $419,580.07. Following the completion of the sale, the insider now directly owns 15,625 shares in the company, valued at $392,031.25. This represents a 51.70% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. Company insiders own 8.60% of the company's stock.

Schrödinger Company Profile

Schrödinger, Inc, together with its subsidiaries, develops physics-based computational platform that enables discovery of novel molecules for drug development and materials applications. The company operates in two segments, Software and Drug Discovery. The Software segment is focused on licensing its software to transform molecular discovery for life sciences and materials science industries.